homovanillic acid has been researched along with Apoplexy in 2 studies
Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De la Torre, R | 1 |
| Corella, D | 1 |
| Castañer, O | 1 |
| Martínez-González, MA | 1 |
| Salas-Salvado, J | 1 |
| Vila, J | 1 |
| Estruch, R | 1 |
| Sorli, JV | 1 |
| Arós, F | 1 |
| Fiol, M | 1 |
| Ros, E | 1 |
| Serra-Majem, L | 1 |
| Pintó, X | 1 |
| Gómez-Gracia, E | 1 |
| Lapetra, J | 1 |
| Ruiz-Canela, M | 1 |
| Basora, J | 1 |
| Asensio, EM | 1 |
| Covas, MI | 1 |
| Fitó, M | 1 |
| Hama, S | 1 |
| Murakami, T | 1 |
| Yamashita, H | 1 |
| Onoda, K | 1 |
| Yamawaki, S | 1 |
| Kurisu, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Bioavailability and Metabolism of Diet Phenolic Compounds[NCT03614520] | Phase 1 | 20 participants (Actual) | Interventional | 2018-07-09 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for homovanillic acid and Apoplexy
| Article | Year |
|---|---|
Protective effect of homovanillyl alcohol on cardiovascular disease and total mortality: virgin olive oil, wine, and catechol-methylation.
Topics: Aged; Biomarkers; Cardiovascular Diseases; Catechol O-Methyltransferase; Catechols; Cause of Death; | 2017 |
Neuroanatomic pathways associated with monoaminergic dysregulation after stroke.
Topics: Adult; Affective Symptoms; Aged; Aged, 80 and over; Apathy; Basal Ganglia; Biogenic Monoamines; Depr | 2017 |